Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Allergy Immunotherapy Market, by Distribution Channel
1.4.2 North America Allergy Immunotherapy Market, by Treatment Type
1.4.3 North America Allergy Immunotherapy Market, by Allergy Type
1.4.4 North America Allergy Immunotherapy Market, by Country
1.5 Methodology for the research
Chapter 2. Market At a Glance
2.1 Key Highlight
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Forces Analysis
Chapter 4. North America Allergy Immunotherapy Market by Distribution Channel
4.1 North America Retail Pharmacy Market by Country
4.2 North America Hospital Pharmacy Market by Country
4.3 North America Online Pharmacy Market by Country
Chapter 5. North America Allergy Immunotherapy Market by Treatment Type
5.1 North America Subcutaneous Immunotherapy (SCIT) Market by Country
5.2 North America Sublingual Immunotherapy (SLIT) Market by Country
5.3 North America Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type
5.3.1 North America Tablets Market by Country
5.3.2 North America Drops Market by Country
Chapter 6. North America Allergy Immunotherapy Market by Allergy Type
6.1 North America Allergic Rhinitis Market by Country
6.2 North America Allergic Asthma Market by Country
6.3 North America Others Market by Country
Chapter 7. North America Allergy Immunotherapy Market by Country
7.1 US Allergy Immunotherapy Market
7.1.1 US Allergy Immunotherapy Market by Distribution Channel
7.1.2 US Allergy Immunotherapy Market by Treatment Type
7.1.2.1 US Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type
7.1.3 US Allergy Immunotherapy Market by Allergy Type
7.2 Canada Allergy Immunotherapy Market
7.2.1 Canada Allergy Immunotherapy Market by Distribution Channel
7.2.2 Canada Allergy Immunotherapy Market by Treatment Type
7.2.2.1 Canada Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type
7.2.3 Canada Allergy Immunotherapy Market by Allergy Type
7.3 Mexico Allergy Immunotherapy Market
7.3.1 Mexico Allergy Immunotherapy Market by Distribution Channel
7.3.2 Mexico Allergy Immunotherapy Market by Treatment Type
7.3.2.1 Mexico Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type
7.3.3 Mexico Allergy Immunotherapy Market by Allergy Type
7.4 Rest of North America Allergy Immunotherapy Market
7.4.1 Rest of North America Allergy Immunotherapy Market by Distribution Channel
7.4.2 Rest of North America Allergy Immunotherapy Market by Treatment Type
7.4.2.1 Rest of North America Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type
7.4.3 Rest of North America Allergy Immunotherapy Market by Allergy Type
Chapter 8. Company Profiles
8.1 Viatris, Inc. (Mylan N.V.)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental Analysis
8.1.4 Research & Development Expense
8.1.5 SWOT Analysis
8.2 Merck KGaA
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 SWOT Analysis
8.3 NIOX Group plc
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental Analysis
8.3.4 Research & Development Expenses
8.3.5 SWOT Analysis
8.4 DMS Imaging SA
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 SWOT Analysis
8.5 Adamis Pharmaceuticals Corporation
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Research & Development Expenses
8.5.4 SWOT Analysis
8.6 Stallergenes Greer International AG (B-Flexion)
8.6.1 Company Overview
8.6.2 Recent strategies and developments:
8.6.2.1 Partnerships, Collaborations, and Agreements:
8.6.2.2 Acquisition and Mergers:
8.6.3 SWOT Analysis
8.7 Allergy Therapeutics plc
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental Analysis
8.7.4 Research & Development Expenses
8.7.5 SWOT Analysis
8.8 DBV Technologies S.A.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Research & Development Expenses
8.8.4 SWOT Analysis
8.9 HAL Allergy B.V. (Droege International Group AG.)
8.9.1 Company Overview
8.9.2 SWOT Analysis
8.10. LETI Pharma, S.L.U.
8.10.1 Company Overview
Unique Offerings 